|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MAGNA LAB INC, 10QSB, EX-10.42, 2000-10-16 |
Next: ENCHIRA BIOTECHNOLOGY CORP, SC 13D, 2000-10-16 |
<TABLE> <S> <C>
<ARTICLE> 5
<CURRENCY> US DOLLARS
<S> <C>
<PERIOD-TYPE> 6-MOS
<FISCAL-YEAR-END> FEB-28-2001
<PERIOD-START> MAR-01-2000
<PERIOD-END> AUG-31-2000
<EXCHANGE-RATE> 1
<CASH> 1,836,000
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 2,966,000
<PP&E> 409,000
<DEPRECIATION> 402,000
<TOTAL-ASSETS> 2,973,000
<CURRENT-LIABILITIES> 666,000
<BONDS> 0
0
0
<COMMON> 40,000
<OTHER-SE> 2,267,000
<TOTAL-LIABILITY-AND-EQUITY> 2,973,000
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 717,000
<OTHER-EXPENSES> (42,000)
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 0
<INCOME-PRETAX> (675,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (675,000)
<EPS-BASIC> 0.2
<EPS-DILUTED> 0.2
</TABLE>
|
|